Magnetic hybrid Pd/Fe-oxide nanoparticles meet the demands for ablative thermo-brachytherapy

References

• Gas P. Essential facts on the history of hyperthermia and their connections with electromedicine. Przegl Elektrotech. 2011;87:37–40.
   Google Scholar
• Falk MH, Issels RD. Hyperthermia in oncology. Int J Hyperthermia. 2001;17(1):1–18. doi: 10.1080/02656730150201552.
   PubMed Web of Science ®Google Scholar
• Stauffer PR, Goldberg SN. Introduction: thermal ablation therapy. Int J Hyperthermia. 2004;20(7):671–677. doi: 10.1080/02656730400007220.
   PubMed Web of Science ®Google Scholar
• Kozissnik B, Bohorquez AC, Dobson J, et al. Magnetic fluid hyperthermia: advances, challenges, and opportunity. Int J Hyperthermia. 2013;29(8):706–714. doi: 10.3109/02656736.2013.837200.
   PubMed Web of Science ®Google Scholar
• Giustini AJ, Petryk AA, Cassim SM, et al. Magnetic nanoparticle hyperthermia in cancer treatment. Nano Life. 2010;1(02):17–32. doi: 10.1142/S1793984410000067.
   Google Scholar
• Ashikbayeva Z, Tosi D, Balmassov D, et al. Application of nanoparticles and nanomaterials in thermal ablation therapy of cancer. Nanomaterials (Basel). 2019;9(9):1195. doi: 10.3390/nano9091195.
   Google Scholar
• Jordan A. Hyperthermia classic commentary: ‘Inductive heating of ferrimagnetic particles and magnetic fluids: physical evaluation of their potential for hyperthermia’ by andreas Jordan et al., international journal of hyperthermia, 1993;9:51-68. Int J Hyperthermia. 2009;25(7):512–516. doi: 10.3109/02656730903183445.
   PubMed Web of Science ®Google Scholar
• Jordan A, Wust P, Fähling H, et al. Inductive heating of ferrimagnetic particles and magnetic fluids—physical evaluation of their potential for hyperthermia. Int J Hyperthermia. 1993;9(1):51–68. doi: 10.3109/02656739309061478.
   PubMed Web of Science ®Google Scholar
• Dennis CL, Ivkov R. Physics of heat generation using magnetic nanoparticles for hyperthermia. Int J Hyperthermia. 2013;29(8):715–729. doi: 10.3109/02656736.2013.836758.
   PubMed Web of Science ®Google Scholar
• Soetaert F, Korangath P, Serantes D, et al. Cancer therapy with iron oxide nanoparticles: agents of thermal and immune therapies. Adv Drug Deliv Rev. 2020;163–164:65–83. doi: 10.1016/j.addr.2020.06.025.
   PubMed Web of Science ®Google Scholar
• Thiesen B, Jordan A. Clinical applications of magnetic nanoparticles for hyperthermia. Int J Hyperthermia. 2008;24(6):467–474. doi: 10.1080/02656730802104757.
   PubMed Web of Science ®Google Scholar
• Andreu I, Natividad E. Accuracy of available methods for quantifying the heat power generation of nanoparticles for magnetic hyperthermia. Int J Hyperthermia. 2013;29(8):739–751. doi: 10.3109/02656736.2013.826825.
   PubMed Web of Science ®Google Scholar
• Wells J, Ortega D, Steinhoff U, et al. Challenges and recommendations for magnetic hyperthermia characterization measurements. Int J Hyperthermia. 2021;38(1):447–460. doi: 10.1080/02656736.2021.1892837.
   PubMed Web of Science ®Google Scholar
• Brem RF. Radiofrequency ablation of breast cancer: a step forward. Radiology. 2018;289(2):325–326. doi: 10.1148/radiol.2018181784.
   PubMed Web of Science ®Google Scholar
• van de Voort EM, Struik GM, Birnie E, et al. Thermal ablation as an alternative for surgical resection of small (≤2 cm) breast cancers: a meta-analysis. Clin Breast Cancer. 2021;21(6):e715–e730. doi: 10.1016/j.clbc.2021.03.004.
   Web of Science ®Google Scholar
• Zulkifli D, Manan HA, Yahya N, et al. The applications of high-intensity focused ultrasound (HIFU) ablative therapy in the treatment of primary breast cancer: a systematic review. Diagnostics (Basel). 2023;13(15):2595. doi: 10.3390/diagnostics13152595.
   Google Scholar
• van de Voort EMF, Struik GM, Koppert LB, et al. Treatment of early-stage breast cancer with percutaneous thermal ablation, an open-label randomised phase 2 screening trial: rationale and design of the THERMAC trial. BMJ Open. 2021;11(9):e052992. doi: 10.1136/bmjopen-2021-052992.
   Web of Science ®Google Scholar
• García-Tejedor A, Guma A, Soler T, et al. Radiofrequency ablation followed by surgical excision versus lumpectomy for early stage breast cancer: a randomized phase II clinical trial. Radiology. 2018;289(2):317–324. doi: 10.1148/radiol.2018180235.
   PubMed Web of Science ®Google Scholar
• Alphandéry E. Perspectives of breast cancer thermotherapies. J Cancer. 2014;5(6):472–479. doi: 10.7150/jca.8693.
   PubMed Web of Science ®Google Scholar
• Hilger I, Andrä W, Hergt R, et al. Magnetische thermotherapie von tumoren der brust: ein experimenteller therapieansatz. Rofo. 2005;177(4):507–515. doi: 10.1055/s-2005-858021.
   Google Scholar
• Maier A, van Oossanen R, van Rhoon GC, et al. From structure to function: understanding synthetic conditions in relation to magnetic properties of hybrid Pd/Fe-oxide nanoparticles. Nanomaterials (Basel). 2022;12(20):3649. doi: 10.3390/nano12203649.
   Google Scholar
• van Oossanen RG, Brown JMC, Maier A, et al. Feasibility study on the radiation dose by radioactive magnetic core-shell nanoparticles for open-source brachytherapy. Cancers (Basel). 2022;14(22):5497. doi: 10.3390/cancers14225497.
   Web of Science ®Google Scholar
• Meattini I, Becherini C, Boersma L, et al. European society for radiotherapy and oncology advisory committee in radiation oncology practice consensus recommendations on patient selection and dose and fractionation for external beam radiotherapy in early breast cancer. Lancet Oncol. 2022;23(1):e21–e31. doi: 10.1016/S1470-2045(21)00539-8.
   Web of Science ®Google Scholar
• Atkinson WJ, Brezovich IA, Chakraborty DP. Usable frequencies in hyperthermia with thermal seeds. IEEE Trans Biomed Eng. 1984;31(1):70–75. doi: 10.1109/TBME.1984.325372.
   PubMed Web of Science ®Google Scholar
• Dutz S, Hergt R. Magnetic nanoparticle heating and heat transfer on a microscale: basic principles, realities and physical limitations of hyperthermia for tumour therapy. Int J Hyperthermia. 2013;29(8):790–800. doi: 10.3109/02656736.2013.822993.
   PubMed Web of Science ®Google Scholar
• Natividad E, Castro M, Mediano A. Adiabatic vs. non-adiabatic determination of specific absorption rate of ferrofluids. J Magn Magn Mater. 2009;321(10):1497–1500. doi: 10.1016/j.jmmm.2009.02.072.
   Web of Science ®Google Scholar
• Wildeboer R, Southern P, Pankhurst Q. On the reliable measurement of specific absorption rates and intrinsic loss parameters in magnetic hyperthermia materials. J Phys D: Appl Phys. 2014;47(49):495003. doi: 10.1088/0022-3727/47/49/495003.
   Web of Science ®Google Scholar
• Gonzalez-Fernandez M, Torres T, Andrés-Vergés M, et al. Magnetic nanoparticles for power absorption: optimizing size, shape and magnetic properties. J Solid State Chem. 2009;182(10):2779–2784. doi: 10.1016/j.jssc.2009.07.047.
   Web of Science ®Google Scholar
• Salunkhe AB, Khot VM, Pawar SH. Magnetic hyperthermia with magnetic nanoparticles: a status review. Curr Top Med Chem. 2014;14(5):572–594. doi: 10.2174/1568026614666140118203550.
   PubMed Web of Science ®Google Scholar
• Deatsch AE, Evans BA. Heating efficiency in magnetic nanoparticle hyperthermia. J Magn Magn Mater. 2014;354:163–172. doi: 10.1016/j.jmmm.2013.11.006.
   Web of Science ®Google Scholar
• Obaidat IM, Narayanaswamy V, Alaabed S, et al. Principles of magnetic hyperthermia: a focus on using multifunctional hybrid magnetic nanoparticles. Magnetochemistry. 2019;5(4):67. doi: 10.3390/magnetochemistry5040067.
   Web of Science ®Google Scholar
• Vassallo M, Martella D, Barrera G, et al. Improvement of hyperthermia properties of iron oxide nanoparticles by surface coating. ACS Omega. 2023;8(2):2143–2154. doi: 10.1021/acsomega.2c06244.
   Web of Science ®Google Scholar
• Jiang Q, Ren F, Wang C, et al. On the magnetic nanoparticle injection strategy for hyperthermia treatment. Int J Mech Sci. 2022;235:107707. doi: 10.1016/j.ijmecsci.2022.107707.
   Web of Science ®Google Scholar
• Salloum M, Ma R, Zhu L. Enhancement in treatment planning for magnetic nanoparticle hyperthermia: optimization of the heat absorption pattern. Int J Hyperthermia. 2009;25(4):309–321. doi: 10.1080/02656730902803118.
   PubMed Web of Science ®Google Scholar
• Di Barba P, Dughiero F, Sieni E. Synthesizing distributions of magnetic nanoparticles for clinical hyperthermia. IEEE Trans Magn. 2012;48(2):263–266. doi: 10.1109/TMAG.2011.2174340.
   Web of Science ®Google Scholar
• Tang Y-D, Jin T, Flesch RC, et al. Simultaneous optimization of injection dose and location for magnetic hyperthermia using metaheuristic algorithms. IEEE Trans Magn. 2020;56(1):1–6. doi: 10.1109/TMAG.2019.2949933.
   Web of Science ®Google Scholar
• Rodrigues HF, Capistrano G, Bakuzis AF. In vivo magnetic nanoparticle hyperthermia: a review on preclinical studies, low-field nano-heaters, noninvasive thermometry and computer simulations for treatment planning. Int J Hyperthermia. 2020;37(3):76–99. doi: 10.1080/02656736.2020.1800831.
   PubMed Web of Science ®Google Scholar
• Hergt R, Dutz S. Magnetic particle hyperthermia—biophysical limitations of a visionary tumour therapy. J Magn Magn Mater. 2007;311(1):187–192. doi: 10.1016/j.jmmm.2006.10.1156.
   Web of Science ®Google Scholar
• Singh S, Melnik R. Thermal ablation of biological tissues in disease treatment: a review of computational models and future directions. Electromagn Biol Med. 2020;39(2):49–88. doi: 10.1080/15368378.2020.1741383.
   PubMed Web of Science ®Google Scholar
• Soetaert F, Kandala SK, Bakuzis A, et al. Experimental estimation and analysis of variance of the measured loss power of magnetic nanoparticles. Sci Rep. 2017;7(1):6661. doi: 10.1038/s41598-017-07088-w.
   PubMed Web of Science ®Google Scholar